The widespread acceptance of the so-called GLP-1 drugs, Zepbound by Eli Lilly and Wegovy by Novo Nordisk, for weight loss has created a game-changing dynamic for the overall health of the 72% of ...

For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.

Olfactive Biosolutions’ Pivit GLP-1 Weight Management activates olfactory receptors in the gut to induce the secretion of natural GLP-1 and GIP to facilitate weight management and regulation of blood ...

ranks as one of the most popular weight loss drugs in the world followed by two more Novo Nordisk drugs, Rybelsus and Wegovy. The combined sales of this trio reached $21.1 billion in 2023 — an ...

With obesity rates tripling over the past 60 years, GLP-1 medications dominated the conversation in 2024 as an effective solution for this pervasive issue. But are they a one-shot deal?

GLP-1s, the popular medications helping millions of people lose weight by curbing their appetites ... Another report from Circana found that GLP-1 users traditionally spent more at c-stores ...

1. Nearly two-thirds say their shopping habits have changed since they began taking a GLP-1 medication for weight loss. GLP-1 users are increasingly shifting their clothing preferences, with recent ...

She also mentioned that it's a "crazy" coincidence that the album's success coincided with its 15-year anniversary. Pratt humorously remarked on his social media about the situation, jokingly ...

Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The ...

morgantown, w.va. – Millions of obese Americans have achieved successful weight loss through use of glucagon-like peptide-1 agonists (GLP-1), a game-changing class of obesity medications.